Abstract:Objective: Our objective was to characterize the safety and efficacy of the 180 W XPS-GreenLight laser in men with lower urinary tract symptoms secondary to a small volume benign prostatic hyperplasia (BPH). Methods: A retrospective analysis was performed for all patients who underwent 180 W XPS-laser photoselective vaporization of the prostate (PVP) vaporization of the prostate between 2012 and 2016 at two-tertiary medical centers. Data collection included baseline comorbidities, disease-specific quality of life scores, maximum urinary flow rate (Qmax), postvoid residual (PVR), complications, prostate volume and prostate-specific antigen (PSA). The secondary endpoints were the incidence of intraoperative and postoperative adverse events. Complications were stratified using the Clavien-Dindo grading system up to 90 days after surgery. Results: Mean age of men was 67.8 years old, with a mean body mass index of 29.7 kg/m2. Mean prostate volume as measured by transrectal ultrasound was 29 mL. Anticoagulation use was 47% and urinary retention with catheter at time of surgery was 17%. Mean hospital stay and catheter time were 0.5 days. Median follow-up time was 6 months with the longest duration of follow-up being 22.5 months (interquartile range, 3-22.5 months). The International Prostate Symptom Score improved from 22.8 ± 7.0 at baseline to 10.7 ± 7.4 (p < 0.01) and 6.3 ± 4.4 (p < 0.01) at 1 and 6 months, respectively. The Qmax improved from 7.70 ± 4.46 mL/s at baseline to 17.25 ± 9.30 mL/s (p < 0.01) and 19.14 ± 7.19 mL/s (p < 0.001) at 1 and 6 months, respectively, while the PVR improved from 216.0 ± 271.0 mL preoperatively to 32.8 ± 45.3 mL (p < 0.01) and 26.2 ± 46.0 mL (p < 0.01) at 1 and 6 months, respectively. The PSA dropped from 1.97 ± 1.76 ng/mL preoperatively to 0.71 ± 0.61 ng/mL (p < 0.01) and 0.74 ± 0.63 ng/mL at 1 and 6 months, respectively. No patient had a bladder neck contracture postoperatively and no capsular perforations were noted intraoperatively. Conclusion: The 180 W GreenLight XPS system is safe and effective for men with small volume BPH. PVP produced improvements in symptomatic and clinical parameters without any safety concern. It represents a safe surgical option in this under studied population.

160-Watt Domestic High Power Greenlight Photoselective Vaporization of Large-Gland Benign Prostatic Hyperplasia

Evaluation of 80-W and 120-W GreenLight Laser Vaporization for Benign Prostatic Hyperplasia in High-Risk Patients

Efficacy of GreenLight 180 W vs.120 W laser systems in the treatment of high-risk benign prostate hyperplasia in elderly patients with prostate over 80 g

Clinical efficiency of 120W diode laser vaporization for benign prostate hyperplasia：report of 57 cases

Greenlight photoselective vaporization prostatectomy for the treatment of benign prostatic hyperplasia

Effect of Straight Light Beam Greenlight PVP for the Treatment of Benign Prostatic Hyperplasia

Comparison of Vaporization Using 120-W GreenLight Laser Versus 2-Micrometer Continuous Laser for Treating Benign Prostatic Hyperplasia: A 24-Month Follow-Up Study of a Single Center

Two Micron Continuous Wave Laser Vaporesection for the Treatment of Benign Prostatic Hyperplasia

[Effect and safety of GreenLight HPS 120-W laser vaporization of the prostate for different benign prostatic hyperplasia populations]

Photo-Selective Vaporization Of The Prostate With Green-Light Hps 120-W Laser For Benign Prostatic Hyperplasia: 36 Months' Follow-Up

GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a prospective randomized trial.

Clinical research on the treatment of benign prostatic hyperplasia patients complicated with bladder cal‐culi with 160 W green‐light laser photoselective vaporization of prostate and transurethral holmium laser cystolithotripsy

Critical Reviews of 1470-Nm Laser Vaporization on Benign Prostatic Hyperplasia.

[Transurethral 180 W front-firing GreenLight laser vaporization of the prostate for the treatment of benign prostatic hyperplasia]

Clinical observation of bipolar plasmakinetic combined with green laser in treatment of larger volume benign prostate hyperplasia

High power dual ceralas laser vaporization for benign prostatic hyperplasia

The role of photovaporization of the prostate in small volume benign prostatic hyperplasia and review of the literature

Experience of treating high risk prostate hyperplasia patients with a HPS120 laser

The Application of 120-W High-Performance System GreenLight Laser Vaporization of the Prostate in High-Risk Patients

"Five-Step" Vaporization of the Prostate Using 180-W XPS Greenlight Laser in Patients with Benign Prostatic Hyperplasia of Large Volume: Improved Efficacy and Safety

Evaluation of Green Light PVP on Treating High-Risk Old Patients with Benign Prostatic Hyperplasia